本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Tyra Biosciences, Inc.

33.79
-1.2750-3.64%
盤後33.790.00000.00%17:59 EDT
成交量:117.42萬
成交額:3,990.88萬
市值:20.10億
市盈率:-16.79
高:36.37
開:34.92
低:33.30
收:35.06
52周最高:40.65
52周最低:8.75
股本:5,948.52萬
流通股本:2,507.09萬
量比:1.33
換手率:4.68%
股息:- -
股息率:- -
每股收益(TTM):-2.0125
每股收益(LYR):-2.0125
淨資產收益率:-39.83%
總資產收益率:-25.68%
市淨率:7.75
市盈率(LYR):-16.79

資料載入中...

2026/04/24

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/17

重要事件披露

Form 8-K - Current report
2026/04/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/07

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/02

重要事件披露

Form 8-K - Current report
2026/03/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/04

重要事件披露

Form 8-K - Current report
2026/03/02

重要事件披露

Form 8-K - Current report
2026/03/02

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/01

重要事件披露

Form 8-K - Current report
2025/11/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities